The Who-When-Why Triangle of CAM Use Among Portuguese IBD Patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.17/2856 |
Resumo: | BACKGROUND: The use of complementary and alternative medicines is increasing among chronic patients, particularly those afflicted with inflammatory bowel diseases. AIM: This study aimed to address the prevalence of complementary and alternative medicines use among Portuguese inflammatory bowel diseases' patients. METHODS: Patients were invited to fill an anonymous questionnaire concerning the use of complementary and alternative medicines. RESULTS: Thirty-one per cent of the patients reported having used complementary and alternative medicines in the past, whereas 12% were using them by the time the questionnaire was administered. Fifty-nine per cent of the users did not share this information with their physician, whereas 14% and 8% discontinued their medication and periodical examination, respectively. Steroids prescription (OR=2.880) and a higher instruction level (OR=3.669) were predictors of complementary and alternative medicines use in this cohort. CONCLUSIONS: Roughly a third of Portuguese IBD patients had used CAM. Steroid treatment and an academic degree are associated with CAM use. Given the potential side effects and interactions, patient information about the benefits and limitations of conventional and complementary treatments should be reinforced. |
id |
RCAP_4f23304b9fd33c702e8e0c0ac880b235 |
---|---|
oai_identifier_str |
oai:repositorio.chlc.min-saude.pt:10400.17/2856 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
The Who-When-Why Triangle of CAM Use Among Portuguese IBD PatientsAdultCohort StudiesComplementary TherapiesFemaleHumansInflammatory Bowel DiseasesLogistic ModelsMaleMiddle AgedPatient CompliancePortugalSteroidsSurveys and QuestionnairesTreatment OutcomeCHLC GASBACKGROUND: The use of complementary and alternative medicines is increasing among chronic patients, particularly those afflicted with inflammatory bowel diseases. AIM: This study aimed to address the prevalence of complementary and alternative medicines use among Portuguese inflammatory bowel diseases' patients. METHODS: Patients were invited to fill an anonymous questionnaire concerning the use of complementary and alternative medicines. RESULTS: Thirty-one per cent of the patients reported having used complementary and alternative medicines in the past, whereas 12% were using them by the time the questionnaire was administered. Fifty-nine per cent of the users did not share this information with their physician, whereas 14% and 8% discontinued their medication and periodical examination, respectively. Steroids prescription (OR=2.880) and a higher instruction level (OR=3.669) were predictors of complementary and alternative medicines use in this cohort. CONCLUSIONS: Roughly a third of Portuguese IBD patients had used CAM. Steroid treatment and an academic degree are associated with CAM use. Given the potential side effects and interactions, patient information about the benefits and limitations of conventional and complementary treatments should be reinforced.ElsevierRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEPortela, FDias, CCaldeira, PCravo, MDeus, JGonçalves, RLago, PMorna, HPeixe, PRamos, JSousa, HTavares, LVasconcelos, HMagro, FMinistro, P2018-01-23T16:47:45Z2017-042017-04-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/2856engDig Liver Dis. 2017 Apr;49(4):388-396.10.1016/j.dld.2016.12.031info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:40:01Zoai:repositorio.chlc.min-saude.pt:10400.17/2856Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:20:11.406841Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
The Who-When-Why Triangle of CAM Use Among Portuguese IBD Patients |
title |
The Who-When-Why Triangle of CAM Use Among Portuguese IBD Patients |
spellingShingle |
The Who-When-Why Triangle of CAM Use Among Portuguese IBD Patients Portela, F Adult Cohort Studies Complementary Therapies Female Humans Inflammatory Bowel Diseases Logistic Models Male Middle Aged Patient Compliance Portugal Steroids Surveys and Questionnaires Treatment Outcome CHLC GAS |
title_short |
The Who-When-Why Triangle of CAM Use Among Portuguese IBD Patients |
title_full |
The Who-When-Why Triangle of CAM Use Among Portuguese IBD Patients |
title_fullStr |
The Who-When-Why Triangle of CAM Use Among Portuguese IBD Patients |
title_full_unstemmed |
The Who-When-Why Triangle of CAM Use Among Portuguese IBD Patients |
title_sort |
The Who-When-Why Triangle of CAM Use Among Portuguese IBD Patients |
author |
Portela, F |
author_facet |
Portela, F Dias, C Caldeira, P Cravo, M Deus, J Gonçalves, R Lago, P Morna, H Peixe, P Ramos, J Sousa, H Tavares, L Vasconcelos, H Magro, F Ministro, P |
author_role |
author |
author2 |
Dias, C Caldeira, P Cravo, M Deus, J Gonçalves, R Lago, P Morna, H Peixe, P Ramos, J Sousa, H Tavares, L Vasconcelos, H Magro, F Ministro, P |
author2_role |
author author author author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE |
dc.contributor.author.fl_str_mv |
Portela, F Dias, C Caldeira, P Cravo, M Deus, J Gonçalves, R Lago, P Morna, H Peixe, P Ramos, J Sousa, H Tavares, L Vasconcelos, H Magro, F Ministro, P |
dc.subject.por.fl_str_mv |
Adult Cohort Studies Complementary Therapies Female Humans Inflammatory Bowel Diseases Logistic Models Male Middle Aged Patient Compliance Portugal Steroids Surveys and Questionnaires Treatment Outcome CHLC GAS |
topic |
Adult Cohort Studies Complementary Therapies Female Humans Inflammatory Bowel Diseases Logistic Models Male Middle Aged Patient Compliance Portugal Steroids Surveys and Questionnaires Treatment Outcome CHLC GAS |
description |
BACKGROUND: The use of complementary and alternative medicines is increasing among chronic patients, particularly those afflicted with inflammatory bowel diseases. AIM: This study aimed to address the prevalence of complementary and alternative medicines use among Portuguese inflammatory bowel diseases' patients. METHODS: Patients were invited to fill an anonymous questionnaire concerning the use of complementary and alternative medicines. RESULTS: Thirty-one per cent of the patients reported having used complementary and alternative medicines in the past, whereas 12% were using them by the time the questionnaire was administered. Fifty-nine per cent of the users did not share this information with their physician, whereas 14% and 8% discontinued their medication and periodical examination, respectively. Steroids prescription (OR=2.880) and a higher instruction level (OR=3.669) were predictors of complementary and alternative medicines use in this cohort. CONCLUSIONS: Roughly a third of Portuguese IBD patients had used CAM. Steroid treatment and an academic degree are associated with CAM use. Given the potential side effects and interactions, patient information about the benefits and limitations of conventional and complementary treatments should be reinforced. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-04 2017-04-01T00:00:00Z 2018-01-23T16:47:45Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.17/2856 |
url |
http://hdl.handle.net/10400.17/2856 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Dig Liver Dis. 2017 Apr;49(4):388-396. 10.1016/j.dld.2016.12.031 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799131297928445952 |